The largest database of trusted experimental protocols

4 protocols using 3 matida

1

Antibody and Pharmacological Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies used in this study include a mouse antibody against mGlu1a (RRID:AB_396369; BD Biosciences, San Jose, CA), postsynaptic density protein 95 (PSD-95) (RRID:AB_2292909; UC Davis/NIH NeuroMab Facility, Davis, CA), or α-actinin (RRID:AB94325; MilliporeSigma, Billerica, MA), or a rabbit antibody against mGlu5 (RRID:AB_2295173; MilliporeSigma), calnexin (RRID:AB_2243890; Santa Cruz Biotechnology, Dallas, TX), or actin (RRID:AB_476693; MilliporeSigma). Validation data for antibodies are available from the companies. Pharmacological agents include 3-methyl-aminothiophene dicarboxylic acid (3-MATIDA, Tocris Bioscience, Minneapolis, MN), 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine hydrochloride (MTEP, Tocris), and (RS)-3,5-dihydroxyphenylglycine (DHPG, Tocris). All drugs were freshly prepared at the day of experiments.
+ Open protocol
+ Expand
2

Neuropharmacology Receptor Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents were obtained from the following sources: (−) Nicotine hydrogen tartrate salt [nAChR agonist] (N5260, Millipore Sigma, 2013), (+)-MK-801 Maleate [NMDAR antagonist] (0924, Ascent Scientific, 2009), and APV [NMDAR antagonist] (A5282, Millipore Sigma, 2012); MLA [α7 nAChR antagonist] (1029, Tocris Biosciences, 2015), MPEP [mGluR5 antagonist] (1212, Tocris Biosciences, 2015), and 3-MATIDA [mGluR1 antagonist] (2196, Tocris Biosciences, 2015), Gabazine [GABAAR antagonist] (1262, Tocris Biosciences, 2009). Sazetidine-A (SAZ-A) tartrate [α4β2 nAChR partial agonist] was synthesized by Drs. Milton L. Brown, Mikell A. Paige, and Brian E. McDowell (Georgetown University, Washington, DC) and kindly provided by Dr. Kenneth Kellar (Georgetown University, 2015) (Xiao et al. 2006 (link)). AT-1001 [α3β4 nAChR partial agonist] was a gift from Astraea Therapeutics (Mountain View, CA, USA, 2012) (Zaveri et al. 2010 (link)).
+ Open protocol
+ Expand
3

Reagents for Neuroscience Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
(S)-3,5-dihydroxyphenylglycine (DHPG), (S)-(+)-α-amino-a-methylbenzeneacetic acid (LY 367385), MPEP, 3-MATIDA, WIN 55,212-2, CP 55940, AM 251, bicuculline and gabazine were purchased from Tocris (Bristol, UK). QX 314 was from Alomone laboratories (Jerusalem, Israel) and URB 602 was from Cayman Chemical (Ann Arbor, MI, USA). Tissue culture reagents were obtained from Gibco-BRL (San Giuliano Milanese, MI, Italy) and ICN Pharmaceuticals (Opera, MI, Italy). Propidium iodide (PI) was purchased from Molecular Probes (Leiden, the Netherlands). If not otherwise declared, all cell culture media were purchased from Sigma-Aldrich (Darmstadt, Germany).
+ Open protocol
+ Expand
4

Characterization of Pharmacological Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
2-Bromo-α-ergocryptine methanesulfonate salt (BRM) was purchased from Sigma-Aldrich. Aprepitant was obtained from Selleck. All the other compounds tested were purchased from Tocris Biosciences, including SCH 23390 hydrochloride, rotigotine hydrochloride, sumanirole maleate, B-HT 920, Ro 10-5824 dihydrochloride, YM 202074, cinnabarinic acid, MTP, ICI 118,551 hydrochloride, GS 6201, PSB 1115, SC 19220, CP 154526, L-733060, CP 96345, TAM, DOX, A 412997 dihydrochloride, AMN 082 dihydrochloride, SKF 97541, Rac BHFF, SEW 2871, purmorphamine, (R)-(−)-α-methylhistamine dihydrobromide, methimepip dihydrobromide, VU 0155041 sodium salt, antalarmin hydrochloride, NBI 35965 hydrochloride, BQ 788 sodium salt, BAY36-7620, 3-MATIDA, MPEP hydrochloride, MRS 1754, SC 51322, SC 19220, and JTE 013.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!